Nexavar多吉美

Nexavar Indications/Uses

sorafenib

Manufacturer:

Bayer

Distributor:

Zuellig
/
Firma Chun Cheong
Full Prescribing Info
Indications/Uses
Hepatocellular Carcinoma (HCC): Nexavar is indicated for the treatment of hepatocellular carcinoma (see Pharmacology: Pharmacodynamics under Actions).
Renal Cell Carcinoma (RCC): Nexavar is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-α or interleukin-2 based therapy or are considered unsuitable for such therapy.
Differentiated Thyroid Carcinoma (DTC): Nexavar is indicated for the treatment of patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma, refractory to radioactive iodine.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in